珠海保税区丽珠合成制药有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
29
NMPA:29
Drug Approvals
Ranitidine Bismuth Citrate
- Product Name
- 枸橼酸铋雷尼替丁
- Approval Number
- 国药准字H20153073
- Approval Date
- Dec 31, 2024
NMPA
Anhrdrous Sodium Carbonate
- Product Name
- 无水碳酸钠
- Approval Number
- 国药准字H20173372
- Approval Date
- May 31, 2022
NMPA
Ceftazidime/Sodium Carbonate
- Product Name
- 头孢他啶/碳酸钠
- Approval Number
- 国药准字H20073731
- Approval Date
- May 16, 2022
NMPA
Perospirone Hydrochloride
- Product Name
- 盐酸哌罗匹隆
- Approval Number
- 国药准字H20080132
- Approval Date
- May 16, 2022
NMPA
- Prev
- 1
- 2
- 3
- Next
Clinical Trials
No trials found
News
No news found